SUBTYPES OF NONTRANSFORMED HUMAN MAMMARY EPITHELIAL-CELLS CULTURED IN-VITRO - HISTO-BLOOD GROUP ANTIGEN-H TYPE-2 DEFINES BASAL CELL-DERIVED CELLS

被引:21
作者
KARSTEN, U
PAPSDORF, G
PAULY, A
VOJTESEK, B
MOLL, R
LANE, EB
CLAUSEN, H
STOSIEK, P
KASPER, M
机构
[1] MASARYK INST ONCOL, BRNO, CZECHOSLOVAKIA
[2] UNIV MAINZ, DEPT PATHOL, W-6500 MAINZ, GERMANY
[3] UNIV DUNDEE, DEPT ANAT & PHYSIOL, CAN RES CAMPAIGN LABS, DUNDEE DD1 4HN, SCOTLAND
[4] UNIV COPENHAGEN, FAC HLTH SCI, SCH DENT, DEPT ORAL DIAGNOST, DK-1168 COPENHAGEN, DENMARK
[5] KLINIKUM GORLITZ, INST PATHOL, GORLITZ, GERMANY
关键词
D O I
10.1111/j.1432-0436.1993.tb01588.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Normal (non-transformed) human mammary epithelial cell lines derived from reduction mammoplasties were analyzed by immunocytochemistry with more than 80 monoclonal antibodies (mAbs) and other specific reagents to tissue-specific and developmentally regulated. antigens at different passage levels. A subpopulation of poorly differentiated, proliferating epithelial cells, corresponding to the 'selected' cell type of late passages, is shown to be characterized by a new marker, the histo-blood group antigen H type 2, probably carried on a membrane-bound glycolipid. These cells also express a number of other onco-developmental carbohydrate antigens [Le(y), Le(x), sialosyl-Le(a), precursor of Thomsen Friedenreich antigen (T(n)), but not Thomsen-Friedenreich antigen and sialosyl-T(n)]. Their cytokeratin (CK) phenotype, as assessed by reactivity with monospecific mAbs and two-dimensional gel electrophoresis, is CK 5, 6, 14 and 17, with CK 19 being consistently absent, and varying minor amounts of CK 7, 8 and 18, as well as 15 and 16. The reactivity of these cells with a panel of 11 mAbs specific for CK 18 varies considerably even after cloning, indicating heterogeneity of epitope expression or accessibility. Our data strongly suggest that the H type 2+ cells develop from the basal cell layer of the mammary gland.
引用
收藏
页码:55 / 66
页数:12
相关论文
共 86 条
  • [1] ACHSTATTER T, 1986, METHOD ENZYMOL, V134, P355
  • [2] BARTEK J, 1985, J CELL SCI, V75, P17
  • [3] PATTERNS OF EXPRESSION OF KERATIN-19 AS DETECTED WITH MONOCLONAL-ANTIBODIES IN HUMAN-BREAST TISSUES AND TUMORS
    BARTEK, J
    TAYLORPAPADIMITRIOU, J
    MILLER, N
    MILLIS, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (03) : 299 - 306
  • [4] A SERIES OF 14 NEW MONOCLONAL-ANTIBODIES TO KERATINS - CHARACTERIZATION AND VALUE IN DIAGNOSTIC HISTOPATHOLOGY
    BARTEK, J
    VOJTESEK, B
    STASKOVA, Z
    BARTKOVA, J
    KEREKES, Z
    REJTHAR, A
    KOVARIK, J
    [J]. JOURNAL OF PATHOLOGY, 1991, 164 (03) : 215 - 224
  • [5] BARTEK J, 1987, MOL BIOL DIFFERENTIA, P123
  • [6] BROERS JLV, 1986, J CELL SCI, V83, P37
  • [7] PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES TO HUMAN CASEIN - A MONOCLONAL-ANTIBODY THAT CROSS-REACTS WITH CASEIN AND ALPHA-LACTALBUMIN
    BURCHELL, J
    BARTEK, J
    TAYLORPAPADIMITRIOU, J
    [J]. HYBRIDOMA, 1985, 4 (04): : 341 - 350
  • [8] A MONOCLONAL-ANTIBODY THAT DETECTS MYOEPITHELIAL CELLS IN EXOCRINE GLANDS, BASAL CELLS IN OTHER EPITHELIA AND BASAL AND SUPRABASAL CELLS IN CERTAIN HYPERPLASTIC TISSUES
    CASELITZ, J
    WALTHER, B
    WUSTROW, J
    SEIFERT, G
    WEBER, K
    OSBORN, M
    [J]. VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1986, 409 (05) : 725 - 738
  • [9] DIFFERENTIATING AGENTS IN THE TREATMENT OF HUMAN MALIGNANCIES
    CHESON, BD
    JASPERSE, DM
    CHUN, HG
    FRIEDMAN, MA
    [J]. CANCER TREATMENT REVIEWS, 1986, 13 (03) : 129 - 145
  • [10] MONOCLONAL-ANTIBODIES DIRECTED TO THE BLOOD GROUP-A ASSOCIATED STRUCTURE, GALACTOSYL-A - SPECIFICITY AND RELATION TO THE THOMSEN-FRIEDENREICH ANTIGEN
    CLAUSEN, H
    STROUD, M
    PARKER, J
    SPRINGER, G
    HAKOMORI, S
    [J]. MOLECULAR IMMUNOLOGY, 1988, 25 (02) : 199 - 204